Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Hypertension

Free Subscription Articles published in Clin Cardiol Retrieve available abstracts of 21 articles: HTML format

Single Articles

January 2023
1. BEHNOUSH AH, Khalaji A, Rezaee M, Momtahen S, et al
   Machine learning-based prediction of 1-year mortality in hypertensive patients undergoing coronary revascularization surgery.
   Clin Cardiol. 2023 Jan 1. doi: 10.1002/clc.23963.
   PubMed     Abstract available
   
   
   December 2022
2. LIN L, Huang J, Liu Z, Chen P, et al
   Associations of siesta and total sleep duration with hypertension or cardiovascular diseases in middle-aged and older adults.
   Clin Cardiol. 2022 Dec 12. doi: 10.1002/clc.23954.
   PubMed     Abstract available
   
   
   
3. HUANG Z, Zhong J, Zhang S, Xiong Z, et al
   Association between serum cystatin C and early impairment of cardiac function and structure in type 2 diabetes patients with normal renal function.
   Clin Cardiol. 2022;45:1287-1296.
   PubMed     Abstract available
   
   
   November 2022
4. LIAO LP, Yang Y
   Response to letter to the editor entitled: "Correlation analysis of the triglyceride glucose index and heart failure with preserved ejection fraction in essential hypertensive patients".
   Clin Cardiol. 2022 Nov 20. doi: 10.1002/clc.23943.
   PubMed    
   
   
   
5. MEI K, Ling Q, Yan Z
   Correlation analysis of the triglyceride glucose index and heart failure with preserved ejection fraction in essential hypertensive patients.
   Clin Cardiol. 2022 Nov 20. doi: 10.1002/clc.23944.
   PubMed    
   
   
   
6. SILVA BV, Sousa C, Caldeira D, Abreu A, et al
   Management of arterial hypertension: Challenges and opportunities.
   Clin Cardiol. 2022;45:1094-1099.
   PubMed    
   
   
   October 2022
7. CHENG Q, Zhou D, Wang J, Nie Z, et al
   Sex-specific risk factors of carotid atherosclerosis progression in a high-risk population of cardiovascular disease.
   Clin Cardiol. 2022 Oct 13. doi: 10.1002/clc.23931.
   PubMed     Abstract available
   
   
   September 2022
8. NICHOLS H, Cannon CP, Scirica BM, Fisher NDL, et al
   A remote hypertension management program clinical algorithm.
   Clin Cardiol. 2022 Sep 24. doi: 10.1002/clc.23919.
   PubMed     Abstract available
   
   
   
9. IVEY SL, Hanley HR, Taylor C, Stock E, et al
   Early identification and treatment of women's cardiovascular risk factors prevents cardiovascular disease, saves lives, and protects future generations: Policy recommendations and take action plan utilizing policy levers.
   Clin Cardiol. 2022 Sep 20. doi: 10.1002/clc.23921.
   PubMed     Abstract available
   
   
   
10. SONG W, Zhu J, Zhong Z, Song Y, et al
    Long-term outcome prediction for chronic thromboembolic pulmonary hypertension after pulmonary endarterectomy.
    Clin Cardiol. 2022 Sep 7. doi: 10.1002/clc.23900.
    PubMed     Abstract available
    
    
    July 2022
11. FREEDMAN BL, Berg DD, Scirica BM, Bohula EA, et al
    Epidemiology of heart failure hospitalization in patients with stable atherothrombotic disease: Insights from the TRA 2 degrees P-TIMI 50 trial.
    Clin Cardiol. 2022 Jul 19. doi: 10.1002/clc.23843.
    PubMed     Abstract available
    
    
    
12. KUMAR S, Nikravesh M, Chukwuemeka U, Randazzo M, et al
    Safety of ACEi and ARB in COVID-19 management: A retrospective analysis.
    Clin Cardiol. 2022;45:759-766.
    PubMed     Abstract available
    
    
    June 2022
13. LIAO LP, Yang Y, Wu Y, Li W, et al
    Correlation analysis of the triglyceride glucose index and heart failure with preserved ejection fraction in essential hypertensive patients.
    Clin Cardiol. 2022 Jun 29. doi: 10.1002/clc.23881.
    PubMed     Abstract available
    
    
    April 2022
14. RAZA F, Dharmavaram N, Hess T, Dhingra R, et al
    Distinguishing exercise intolerance in early-stage pulmonary hypertension with invasive exercise hemodynamics: Rest VE /VCO2 and ETCO2 identify pulmonary vascular disease.
    Clin Cardiol. 2022 Apr 14. doi: 10.1002/clc.23831.
    PubMed     Abstract available
    
    
    March 2022
15. XUE L, Yang YC, Zhao Q, Zhao ZH, et al
    The spectrum and prevalence of arrhythmia in different clinical pulmonary hypertension groups in Chinese population.
    Clin Cardiol. 2022 Mar 7. doi: 10.1002/clc.23803.
    PubMed     Abstract available
    
    
    September 2021
16. MONZO L, Ferreira JP, Lamiral Z, Bozec E, et al
    Isolated diastolic hypertension and target organ damage: Findings from the STANISLAS cohort.
    Clin Cardiol. 2021 Sep 15. doi: 10.1002/clc.23713.
    PubMed     Abstract available
    
    
    
17. ZHENG Z, Sun X, Chen R, Lei W, et al
    Comparison of six assessment tools to screen for obstructive sleep apnea in patients with hypertension.
    Clin Cardiol. 2021 Sep 14. doi: 10.1002/clc.23714.
    PubMed     Abstract available
    
    
    July 2021
18. MAEDER MT, Weber L, Weilenmann D, Chronis J, et al
    Impact of the new pulmonary hypertension definition on long-term mortality in patients with severe aortic stenosis undergoing valve replacement.
    Clin Cardiol. 2021 Jul 4. doi: 10.1002/clc.23685.
    PubMed     Abstract available
    
    
    April 2021
19. FERREIRA JP, Gregson J, Bohm M, Rossignol P, et al
    Blood pressure reduction and anti-hypertensive treatment choice: A post-hoc analysis of the SPRINT trial.
    Clin Cardiol. 2021 Apr 6. doi: 10.1002/clc.23591.
    PubMed     Abstract available
    
    
    October 2020
20. BORTNICK AE, Shahid M, Shitole SG, Park M, et al
    Outcomes of ST-elevation myocardial infarction by age and sex in a low-income urban community: The Montefiore STEMI Registry.
    Clin Cardiol. 2020;43:1100-1109.
    PubMed     Abstract available
    
    
    May 2020
21. SNELDER SM, van de Poll SWE, de Groot-de Laat LE, Kardys I, et al
    Optimized electrocardiographic criteria for the detection of left ventricular hypertrophy in obesity patients.
    Clin Cardiol. 2020;43:483-490.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hypertension is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: